Abstract-The objective of this study was to test the hypothesis that renal interstitial (RI) cGMP is natriuretic in vivo. In conscious rats (nϭ8), urinary sodium excretion (U Na V) was significantly greater on days 3 and 4 of RI infusion of cGMP (1.17Ϯ0.14 and 1.61Ϯ0.11 mmol/24 h, respectively) than during vehicle infusion (0.56Ϯ0.15 and 0.70Ϯ0.17 mmol/24 h, respectively) (PϽ0.01). Similarly, U Na V was greater on days 3 and 4 of RI infusion of 8-bromo-cGMP (2.15Ϯ0.42 and 2.16Ϯ0.1 mmol/24 h, respectively). Protein kinase G inhibitor Rp-8-pCPT-cGMPS reduced cGMP-induced and 8-bromo-cGMP-induced U Na V to control levels. Acute RI infusion of L-arginine (L-Arg, 40 mg · kg Ϫ1 · min Ϫ1 ), but not ) increased U Na V from 1.65Ϯ0.11 to 2.93Ϯ0.08 mol/30 min (PϽ0.01), and this response was blocked completely by ODQ. Renal arterial but not RI administration of the heat-stable enterotoxin of Escherichia coli induced natriuresis. RA infusion of cGMP (3 g/min) increased U Na V, renal blood flow (RBF), and glomerular filtration rate (GFR). Renal cortical interstitial cGMP infusion increased U Na V with no effect on total RBF, renal cortical blood flow, or GFR. Similarly, the natriuretic actions of renal interstitial L-Arg or SNAP were not accompanied by any change in RBF or GFR. Medullary cGMP infusion had no effect on U Na V, total RBF, or medullary blood flow. Texas red-labeled cGMP infused via the RI space was distributed exclusively to cortical renal tubular cells. The results demonstrate that RI cGMP inhibits renal tubular sodium absorption via protein kinase G independently of hemodynamic changes. These observations indicate that the cortical interstitial compartment provides a potentially important domain for cell-to-cell signaling within the kidney. Key Words: cyclic GMP Ⅲ kidney Ⅲ natriuresis Ⅲ sodium Ⅲ protein kinases T wo different guanylyl cyclase (GC) enzymes, soluble GC (sGC) and particulate GC (pGC), generate cGMP. 1 sGCs are heterodimers containing heme, which serves as an intercellular receptor for NO. 2,3 In contrast, pGCs are cell membrane receptors for endogenous peptides, including the atriopeptin family and the guanylin peptides: guanylin, uroguanylin, and the heat-stable enterotoxin of Escherichia coli (STa). 4,5 Thus, cGMP may be derived from either cytosolic or cell surface GCs expressed in different cells, depending on the particular hormone or autacoid stimulated.The GC-activating agents, NO and atrial natriuretic peptide, exert potent effects in the kidney, especially on renal blood flow (RBF), glomerular hemodynamics, and urinary sodium excretion (U Na V). 6 -10 Atrial natriuretic peptide or inhibition of cGMP phosphodiesterase (PDE) increases cGMP and causes a marked diuresis and natriuresis. 11-13 NO also stimulates cGMP generation in the vascular system and the kidney. 14,15 NO synthase (NOS) inhibition during regulation of renal perfusion pressure reduces sodium and water excretion, which can be reversed by the cGMP analogue, . 8 However, the relationship of NO generation and cGMP production to...